Medical News

RSS

National Cancer Institute awards PDS Biotechnology $1.28M phase 2 SBIR contract

PDS Biotechnology Corporation today announced that the company has been awarded a $1.28M phase 2 SBIR contract by the National Cancer Institute division of the US National Institutes of Health. The contract provides funding to complete studies required to file an Investigational New Drug Application (IND) with the FDA for the company's lead human papillomavirus (HPV)-cancer product late in 2010.

2 Mar 2010

Cause of abdominal pain in children with no apparent reason: Psychosomatic component

A systematic review that is published in the current issue of Psychotherapy and Psychosomatics by Schulte and associates (University of Bremen, Germany) analyzes what is the psychosomatic component of abdominal pain with no apparent cause in children.

2 Mar 2010

Merge Healthcare introduces new mobile device application for eFilm Workstation v3.3

Merge Healthcare, a leading health IT solutions provider, today announced the release of eFilm Mobile, an exciting new extension of the eFilm Workstation franchise.

2 Mar 2010

Rigel Pharmaceuticals reports net loss of $0.48 per share for fourth-quarter 2009

Rigel Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2009.

2 Mar 2010

Study reveals most consumers are unclear about dietary nutrients

When it comes to dietary nutrients, most consumers don't know the whole story. A recent study by the Innovation Center for U.S. Dairy revealed that the fact that milk delivers much more than calcium to the diet is new "news" to consumers.

2 Mar 2010

Critical follow-up evaluations provide opportunity to help physicians best evaluate their HF patients

Heart failure is by far the most prevalent chronic cardiac condition. Around 30 million people in Europe have heart failure and its incidence is still increasing: more cases are being identified, more people are living to an old age, and more are surviving a heart attack but with damage to the heart muscle.

2 Mar 2010

FDA grants approval to Spectral Diagnostics for pivotal trial of Toraymyxin

Spectral Diagnostics Inc., a company developing products for the treatment of sepsis, today announced that the U.S. Food and Drug Administration has granted Investigational Device Exemption (IDE) approval for Toraymyxin, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream, allowing the Company to conduct a pivotal trial in the United States.

2 Mar 2010

NJIT researcher awarded patent for functional coating compositions of perfluoroalkyl perfluoro-phthalocyanine compounds

Sergiu M. Gorun, PhD, associate professor of chemistry at New Jersey Institute of Technology (NJIT), was awarded a patent today for a novel composition of matter. “Functional Coating Compositions of Perfluoroalkyl Perfluoro-Phthalocyanine Compounds” (US Patent Number 7,670,684) discloses a new self-contained subclass of molecules.

2 Mar 2010

Metropolitan Health Networks reports increased revenue for 2009 fourth quarter

Metropolitan Health Networks, Inc., a leading provider of healthcare services in Florida, today announced the financial results for their fourth quarter and year ended December 31, 2009.

2 Mar 2010

Supercomputer receives powerful supercomputer for biomedical and life sciences research from IBM

Rice University and IBM today unveiled a new high-performance computing initiative for biomedical and life sciences research that features one of the most powerful supercomputers in the Texas Medical Center. Rice scientists will use the supercomputer in collaboration with researchers from across the medical center to study cancer, AIDS and other complex diseases.

2 Mar 2010

MAP Pharmaceuticals announces net loss of $13.4M for fourth-quarter 2009

MAP Pharmaceuticals, Inc. today announced financial results for the fourth quarter and year ended December 31, 2009.

2 Mar 2010

InterMune seeks European marketing approval for pirfenidone

InterMune, Inc. today announced that it has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) seeking approval to market pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF) in the European Union (EU). Currently, there are no EMA-approved treatments for IPF in the EU.

2 Mar 2010

FamilyCord introduces start-of-the-art collection kit for cord blood banking industry

FamilyCord, a subsidiary of California Cryobank, is leading the charge in the private cord blood banking industry for safer, more effective collection kits. FamilyCord's start-of-the-art collection kit is redefining the scientific standards for collection and transport employed by the cord blood banking industry.

2 Mar 2010

Whole Body experts provide tips on how to sustain body's energy

As part of its "Be Good to Your Whole Body campaign in its Whole Body departments, Whole Foods Market focuses on healthy energy for the month of March.

2 Mar 2010

ArQule reports net loss of $36,136,000 for 2009

ArQule, Inc. today announced its financial results for the year and for the fourth quarter ended December 31, 2009.

2 Mar 2010

FDA approves CombinatoRx's NDA for Exalgo extended-release tablets

CombinatoRx, Incorporated today announced that the U.S. Food and Drug Administration has approved the New Drug Application (NDA) for Exalgo™ (hydromorphone HCl) extended-release tablets, for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.

2 Mar 2010

Express Logic, IAR Systems announce commercial-grade integration for embedded application developers

Express Logic, Inc., a worldwide leader in royalty-free real-time operating systems (RTOS), and IAR Systems, a leading provider of software tools for embedded systems, today announced a commercial-grade integration for developers of serious applications.

2 Mar 2010

Imaging technique combining ultrasound and microscopic bubbles help visualize tumor activity at molecular level

An imaging technique combining ultrasound and specially modified contrast agents may allow researchers to noninvasively detect cancer and show its progression, according to research published in the March issue of The Journal of Nuclear Medicine (JNM). The technique enables researchers to visualize tumor activity at the molecular level.

2 Mar 2010

Use of at-home medical devices can help patients and physicians efficiently manage chronic conditions

The use of at-home medical devices to connect doctors and patients via the Internet can help patients and their physicians work more efficiently together to manage chronic conditions, according to research at Cleveland Clinic.

2 Mar 2010

Tampa hospital allows use of electronic cigarettes

As special interest groups and politicians continue to make weak claims against the electric cigarette, another hospital in Tampa, Florida made the decision last week to allow the use of electronic cigarettes within their facility. Smoking is a recreational privilege that while banned in most public places, can be done with the alternative E-cigarette without offending others. This new invention allows the smoker to get their nicotine fix just like the coffee or soda drinkers get their caffeine fix.

2 Mar 2010

Medical News

National Cancer Institute awards PDS Biotechnology $1.28M phase 2 SBIR contract

Cause of abdominal pain in children with no apparent reason: Psychosomatic component

Merge Healthcare introduces new mobile device application for eFilm Workstation v3.3

Rigel Pharmaceuticals reports net loss of $0.48 per share for fourth-quarter 2009

Study reveals most consumers are unclear about dietary nutrients

Critical follow-up evaluations provide opportunity to help physicians best evaluate their HF patients

FDA grants approval to Spectral Diagnostics for pivotal trial of Toraymyxin

NJIT researcher awarded patent for functional coating compositions of perfluoroalkyl perfluoro-phthalocyanine compounds

Metropolitan Health Networks reports increased revenue for 2009 fourth quarter

Supercomputer receives powerful supercomputer for biomedical and life sciences research from IBM

MAP Pharmaceuticals announces net loss of $13.4M for fourth-quarter 2009

InterMune seeks European marketing approval for pirfenidone

FamilyCord introduces start-of-the-art collection kit for cord blood banking industry

Whole Body experts provide tips on how to sustain body's energy

ArQule reports net loss of $36,136,000 for 2009

FDA approves CombinatoRx's NDA for Exalgo extended-release tablets

Express Logic, IAR Systems announce commercial-grade integration for embedded application developers

Imaging technique combining ultrasound and microscopic bubbles help visualize tumor activity at molecular level

Use of at-home medical devices can help patients and physicians efficiently manage chronic conditions

Tampa hospital allows use of electronic cigarettes

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News